---
title: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
date: '2023-07-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37486775/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20230725180810&v=2.17.9.post6+86293ac
source: N Engl J Med
description: 'CONCLUSIONS: Participants with HIV infection who received pitavastatin
  had a lower risk of a major adverse cardiovascular event than those who received
  placebo over a median follow-up of 5.1 years. (Funded by the National Institutes
  of Health and others; REPRIEVE ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Participants with HIV infection who received pitavastatin had a lower risk of a major adverse cardiovascular event than those who received placebo over a median follow-up of 5.1 years. (Funded by the National Institutes of Health and others; REPRIEVE ClinicalTrials.gov number, ...